Skip to main content
Ariel Barkan, MD, Endocrinology, Ann Arbor, MI, University of Michigan Medical Center

ArielLBarkanMD

Endocrinology Ann Arbor, MI

Diabetes, Lipid Metabolism

Physician

Dr. Barkan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Barkan's full profile

Already have an account?

  • Office

    1500 East Medical Center Dr
    2nd Floor Taubman Ctr Recp G
    Ann Arbor, MI 48109
    Phone+1 734-936-5020
    Fax+1 734-936-9294
  • Is this information wrong?

Education & Training

  • University of Michigan Health System
    University of Michigan Health SystemFellowship, Endocrinology, Diabetes, and Metabolism, 1980 - 1983
  • Minsk Medical Institute
    Minsk Medical InstituteClass of 1972

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1983 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Elected Member The American Society for Clinical Investigation, 1993

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Regents Roundup — June 2021
    Regents Roundup — June 2021June 17th, 2021
  • Human Growth Hormone Treatment After ACL Injury May Prevent Loss of Muscle Strength
    Human Growth Hormone Treatment After ACL Injury May Prevent Loss of Muscle StrengthMay 27th, 2020

Grant Support

  • Training Program In Endocrinology And MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2010
  • Defining Growth Hormone Deficiency In AdultsNational Center For Research Resources2006–2007
  • Metabolic Adaptations Of Obesity With GH AdministrationNational Center For Research Resources2005–2006
  • Blockade Of Growth Hormone W/Growth Hormone Releasing Hormone AntagonistNational Center For Research Resources2005–2006
  • Pega-0435-005National Center For Research Resources2004–2006
  • Efficacy/Safety Of Pegvisomant To That Of Sandostatin LAR Depot In AcromegalyNational Center For Research Resources2005
  • Multi-Center, Open-Label Compassionate Use Program To Provide PegvisomantNational Center For Research Resources2004
  • GH Pulsatility In AcromegalyNational Center For Research Resources2004
  • Mechanisms Of Pulsatile Growth Hormone (GH) Secretion In HumansNational Center For Research Resources1999–2002
  • Growth Hormone Releasing Hormone Antagonist Infusion In AcromegalicsNational Center For Research Resources1999–2002
  • Effects Of Growth Hormone Releasing Hormone Antagonist (Ghrh-Ant) On GH ReleaseNational Center For Research Resources1997–2002
  • Pulsatile Administration Of GHRH On Growth Hormone DynamicsNational Center For Research Resources1998–2000
  • Training Program In Endocrinology And Metabolism.National Institute Of Diabetes And Digestive And Kidney Diseases1999
  • Physiopathology Of Pulsatile GH Secretion In HumansNational Institute Of Diabetes And Digestive And Kidney Diseases1995–1998
  • Physiopathology Of Pulsatile GH Secretion In HumansNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1991

Hospital Affiliations